If	O	0,2
left	O	3,7
untreated,	O	8,18
~60%	O	19,23
of	O	24,26
patients	O	27,35
with	O	36,40
EM	B-KP	41,43
develop	O	44,51
brief	O	52,57
recurrent	O	58,67
episodes	O	68,76
of	O	77,79
arthritis,	O	80,90
often	O	91,96
preceded	O	97,105
and	O	106,109
accompanied	O	110,121
by	O	122,124
arthralgias	B-KP	125,136
and	O	137,140
myalgias	B-KP	141,149
[4].	O	150,154

Patients	O	155,163
with	O	164,168
EM	B-KP	169,171
would	O	172,177
be	O	178,180
treated	O	181,188
with	O	189,193
antibiotics	B-KP	194,205
today	O	206,211
and	O	212,215
would	O	216,221
rarely	O	222,228
if	O	229,231
ever	O	232,236
develop	O	237,244
arthritis.	O	245,255

Therefore,	O	256,266
patients	O	267,275
diagnosed	O	276,285
with	O	286,290
LA	B-KP	291,293
today	O	294,299
must	O	300,304
come	O	305,309
mainly	O	310,316
from	O	317,321
those	O	322,327
subsets	O	328,335
of	O	336,338
patients	O	339,347
whose	O	348,353
EM	B-KP	354,356
goes	O	357,361
unnoticed	O	362,371
or	O	372,374
undiagnosed	O	375,386
or	O	387,389
who	O	390,393
do	O	394,396
not	O	397,400
develop	O	401,408
EM	B-KP	409,411
or	O	412,414
any	O	415,418
other	O	419,424
typical	O	425,432
early	O	433,438
manifestations	O	439,453
of	O	454,456
Lyme	B-KP	457,461
disease.	I-KP	462,470

Approximately	O	471,484
one-fourth	O	485,495
of	O	496,498
adults	O	499,505
and	O	506,509
between	O	510,517
16	O	518,520
and	O	521,524
37%	O	525,528
of	O	529,531
children	O	532,540
with	O	541,545
LA	B-KP	546,548
recall	O	549,555
a	O	556,557
tick	O	558,562
bite	O	563,567
[172,247-250].	O	568,582

More	O	583,587
importantly,	O	588,600
almost	O	601,607
30%	O	608,611
of	O	612,614
adults	O	615,621
give	O	622,626
a	O	627,628
history	O	629,636
of	O	637,639
EM	B-KP	640,642
[172],	O	643,649
even	O	650,654
in	O	655,657
case	O	658,662
series	O	663,669
recruited	O	670,679
within	O	680,686
the	O	687,690
last	O	691,695
decade	O	696,702
[247],	O	703,709
while	O	710,715
the	O	716,719
proportion	O	720,730
in	O	731,733
children	O	734,742
has	O	743,746
ranged	O	747,753
between	O	754,761
4	O	762,763
and	O	764,767
18%	O	768,771
in	O	772,774
recent	O	775,781
cohorts	O	782,789
[247,251,252].	O	790,804

According	O	805,814
to	O	815,817
data	O	818,822
from	O	823,827
a	O	828,829
large	O	830,835
vaccine	B-KP	836,843
trial	I-KP	844,849
in	O	850,852
which	O	853,858
participants	O	859,871
were	O	872,876
very	O	877,881
closely	O	882,889
monitored,	O	890,900
16%	O	901,904
of	O	905,907
patients	O	908,916
with	O	917,921
Bb	B-KP	922,924
infection	I-KP	925,934
have	O	935,939
only	O	940,944
systemic	B-KP	945,953
symptoms	I-KP	954,962
(primarily	O	963,973
headaches	B-KP	974,983
and	O	984,987
arthralgias)	B-KP	988,1000
[253]	O	1001,1006
that	O	1007,1011
would	O	1012,1017
not	O	1018,1021
likely	O	1022,1028
be	O	1029,1031
recognized	O	1032,1042
as	O	1043,1045
Lyme	B-KP	1046,1050
disease	I-KP	1051,1058
by	O	1059,1061
the	O	1062,1065
patient	O	1066,1073
or	O	1074,1076
the	O	1077,1080
treating	O	1081,1089
physician.	O	1090,1100

An	O	1101,1103
additional	O	1104,1114
7e11%	O	1115,1120
of	O	1121,1123
the	O	1124,1127
participants	O	1128,1140
show	O	1141,1145
asymptomatic	B-KP	1146,1158
seroconversion	I-KP	1159,1173
[68,254].	O	1174,1183

Even	O	1184,1188
under	O	1189,1194
the	O	1195,1198
worst-case	O	1199,1209
scenario	O	1210,1218
that	O	1219,1223
60%	O	1224,1227
of	O	1228,1230
these	O	1231,1236
two	O	1237,1240
patient	O	1241,1248
subgroups	O	1249,1258
develop	O	1259,1266
LA,	B-KP	1267,1270
one	O	1271,1274
would	O	1275,1280
expect	O	1281,1287
arthritis	O	1288,1297
to	O	1298,1300
be	O	1301,1303
the	O	1304,1307
presenting	O	1308,1318
manifestation	O	1319,1332
in	O	1333,1335
only	O	1336,1340
~16%	O	1341,1345
of	O	1346,1348
patients	O	1349,1357
with	O	1358,1362
Lyme	B-KP	1363,1367
disease	I-KP	1368,1375
in	O	1376,1378
the	O	1379,1382
US.	O	1383,1386

Rather	O	1387,1393
surprisingly,	O	1394,1407
patients	O	1408,1416
with	O	1417,1421
LA	B-KP	1422,1424
continue	O	1425,1433
to	O	1434,1436
represent	O	1437,1446
~30%	O	1447,1451
of	O	1452,1454
the	O	1455,1458
cases	O	1459,1464
reported	O	1465,1473
to	O	1474,1476
the	O	1477,1480
CDC	O	1481,1484
[159].	O	1485,1491

In	O	1492,1494
contrast,	O	1495,1504
the	O	1505,1508
observed	O	1509,1517
rate	O	1518,1522
in	O	1523,1525
large	O	1526,1531
case	O	1532,1536
series	O	1537,1543
of	O	1544,1546
adults	O	1547,1553
and	O	1554,1557
children	O	1558,1566
with	O	1567,1571
Lyme	B-KP	1572,1576
disease	I-KP	1577,1584
has	O	1585,1588
been	O	1589,1593
6%	O	1594,1596
[160,161].	O	1597,1607

In	O	1608,1610
other	O	1611,1616
words,	O	1617,1623
the	O	1624,1627
majority	O	1628,1636
of	O	1637,1639
cases	O	1640,1645
of	O	1646,1648
LA	B-KP	1650,1652
in	O	1653,1655
the	O	1656,1659
US	O	1660,1662
would	O	1663,1668
seem	O	1669,1673
to	O	1674,1676
be	O	1677,1679
preventable.	O	1680,1692

LA	B-KP	1693,1695
constitutes	O	1696,1707
4e8%	O	1708,1712
of	O	1713,1715
cases	O	1716,1721
of	O	1722,1724
Lyme	B-KP	1725,1729
borreliosis	I-KP	1730,1741
in	O	1742,1744
European	O	1745,1753
epidemiological	O	1754,1769
studies	O	1770,1777
[51,53,54,163],	O	1778,1793
although	O	1794,1802
the	O	1803,1806
results	O	1807,1814
of	O	1815,1817
a	O	1818,1819
Swedish	O	1820,1827
study	O	1828,1833
suggest	O	1834,1841
that	O	1842,1846
LA	B-KP	1847,1849
may	O	1850,1853
be	O	1854,1856
underdiagnosed	O	1857,1871
[255].	O	1872,1878

While	O	1879,1884
Lyme	B-KP	1885,1889
disease	I-KP	1890,1897
overall	O	1898,1905
affects	O	1906,1913
men	O	1914,1917
and	O	1918,1921
women	O	1922,1927
with	O	1928,1932
similar	O	1933,1940
frequency,	O	1941,1951
up	O	1952,1954
to	O	1955,1957
75%	O	1958,1961
of	O	1962,1964
adults	O	1965,1971
and	O	1972,1975
70%	O	1976,1979
of	O	1980,1982
children	O	1983,1991
with	O	1992,1996
LA	B-KP	1997,1999
are	O	2000,2003
male	O	2004,2008
not	O	2009,2012
only	O	2013,2017
in	O	2018,2020
the	O	2021,2024
US	O	2025,2027
[4,247,248,250,251,256-258],	O	2028,2056
but	O	2057,2060
also	O	2061,2065
in	O	2066,2068
Europe	O	2069,2075
[170,172,249,259,260].	O	2076,2098

